English
Segment disclosures
Company overviewPOSITIVEID Corp
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
4 dimension combinations 35 retained observations 9 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Medical Devices
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=psid:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 177000 | USD | 20180518 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 411000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 77000 | USD | 20171113 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 349000 | USD | 20171113 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 177000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 272000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 95000 | USD | 20180518 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 417000 | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 145000 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 346000 | USD | 20171113 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 80000 | USD | 20170814 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 200000 | USD | 20170814 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 120000 | USD | 20170515 | Open filing evidence |
Mobile Labs
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=psid:MobileLabsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 4806000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1373000 | USD | 20171113 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 3428000 | USD | 20171113 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 986000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 2055000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 1069000 | USD | 20180518 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 5027000 | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 868000 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 4180000 | USD | 20171113 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1768000 | USD | 20170814 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 3312000 | USD | 20170814 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 1544000 | USD | 20170515 | Open filing evidence |
Mobile Labs · January One Two Thousand And Eighteen Through January Thirty Two Thousand And Eighteen
Statement Business Segments · Award Type
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=psid:MobileLabsMember;us-gaap:AwardTypeAxis=psid:JanuaryOneTwoThousandAndEighteenThroughJanuaryThirtyTwoThousandAndEighteenMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 243000 | USD | 20180518 | Open filing evidence |
Molecular Diagnostics
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=psid:MolecularDiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-12-31 | 142000 | USD | 20180402 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 17000 | USD | 20171113 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 142000 | USD | 20171113 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 62000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 125000 | USD | 20170814 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 63000 | USD | 20180518 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 115000 | USD | 20180402 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 52000 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 52000 | USD | 20171113 | Open filing evidence |